FStar Therapeutics Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. FStar Therapeutics prevailing Real Value cannot be determined due to lack of data. The current price of FStar Therapeutics is $0.0. Our model computes the value of FStar Therapeutics from reviewing the firm fundamentals such as Shares Outstanding of 21.98 M, profit margin of (2.11) %, and Current Valuation of 98.23 M as well as analyzing its technical indicators and probability of bankruptcy.
FStar Therapeutics Total Value Analysis
FStar Therapeutics is currently anticipated to have valuation of 98.23 M with market capitalization of 156.51 M, debt of 9.61 M, and cash on hands of 35.57 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the FStar Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
98.23 M | 156.51 M | 9.61 M | 35.57 M |
FStar Therapeutics Investor Information
About 45.0% of the company shares are owned by institutional investors. The book value of FStar Therapeutics was currently reported as 2.59. The company recorded a loss per share of 1.83. FStar Therapeutics last dividend was issued on the 23rd of November 2020. The entity had 1:4 split on the 23rd of November 2020. Based on the key indicators related to FStar Therapeutics' liquidity, profitability, solvency, and operating efficiency, FStar Therapeutics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.FStar Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. FStar Therapeutics has an asset utilization ratio of 17.21 percent. This suggests that the Company is making $0.17 for each dollar of assets. An increasing asset utilization means that FStar Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.FStar Therapeutics Ownership Allocation
FStar Therapeutics holds a total of 21.98 Million outstanding shares. 30% of FStar Therapeutics outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.FStar Therapeutics Profitability Analysis
The company reported the previous year's revenue of 21.17 M. Net Loss for the year was (31.28 M) with profit before overhead, payroll, taxes, and interest of 21.17 M.FStar Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 20.6 M | |
| Retained Earnings | -78.5 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in FStar Stock
If you are still planning to invest in FStar Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FStar Therapeutics' history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |